Aller au contenu

Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?

Nom du journal : ESMO Open

Année : 2024

Volume : 9

Page de départ : 103701

Auteurs: Valenza, C, Trapani, D, Bidard, FC, Gligorov, J, Cortés, J, Turner, N & al,